Our founder @theallergydoc speaks to the @ACAAI about benefits of intralymphatic immunotherapy (ILIT) a procedure that reduces traditional allergy treatment time from 3 years to 8 weeks #acaai22
It was an honor sharing the stage this morning with @DrAnneEllis, Canadian SLIT expert, who champions SLIT tablets for home-based allergen immunotherapy, a convenient way to manage allergies to select pollens and dust mite. #ACAAI22
It was great presenting on early introduction of foods, baked milk/egg use in allergy and introducing tree nuts to prevent TN allergy with @DrDougMackMD@GroetchMarion and Wendy Elverson RD @AAAAI_org
Dr. Valentine’s keynote on the benefits of diversity and inclusion in academic programs was enlightening. Spoiler alert: The ideas developed by diverse teams benefit everyone!! #InnovationForEveryone https://t.co/R1kb2oyoGi #AAAAI22
What did we learn from the novel allergen immunotherapy dream team? @hjh_Aarhus#ilit is effective in 3 doses (hit that node) @DrShamji is researching a one-shot treatment. And Dr. Nieto is preventing wheeze in kids by fighting viruses with bacteria. #innovation#AAAAI22
It’s hard to get people to stop ordering food panels. But when we stop them we get improved care and cost saving, what’s not to like? #AAAAI22#foodallergy@AllergyKidsDoc your future fellow doing good work!
Wheat allergy reactions in adults varies with all of: amount eaten, presence of exercise and amount of exercise. May be more delayed than other food triggers #AAAAI22
Desensitization to chemotherapy and monoclonals assists management. Session 1801 Practical Guidance for the Evaluation and Management of Drug Hypersensitivity #AAAAI22
…to breathe or not to breathe. #Allergists treat your #asthma and #allergies, so you can #live life the way you want to. Find an allergist near you here https://t.co/WlBxwpxqM3 #AAAAI22
Half of cannabis users with uncontrolled asthma smoke cannabis, feeling positive effects like less anxiety outweigh negative effects such as cough. Session 2005 Diagnostics in Cannabis Allergy #AAAAI22
Children labeled as low risk for drug allergy should have direct oral challenge. Session 1801 Practical Guidance for the Evaluation and Management of Drug Hypersensitivity #AAAAI22